ArticlePharmaceuticals (Basel, Switzerland)2021

Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

Katja S Just et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.